PGE2 decreases reactivity of human platelets by activating EP2 and EP4 - Wikidata - awgldk - TriplyDB

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

http://www.wikidata.org/entity/Q33987096

about

E-type prostanoid receptor 4 (EP4) in disease and therapy Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets Secondary use of clinical data: the Vanderbilt approach Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease The purinergic G protein-coupled receptor 6 inhibits effector T cell activation in allergic pulmonary inflammation Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.An eicosanoid-centric view of atherothrombotic risk factors Prostaglandins temporally regulate cytoplasmic actin bundle formation during Drosophila oogenesis Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Roles of 5-lipoxygenase and cyclooxygenase-2 in the biosynthesis of hemiketals E2 and D2 by activated human leukocytes.

P2860

Q26851156-B54806C9-3C83-4524-B6DD-CB0DF5FB9DE5 Q26998976-35DF9FE0-BD4B-417E-BBD2-20FA1036E6CA Q28654532-F99719BC-76DB-4B9A-AD97-E9D051C96F33 Q34368772-689FB55C-9B51-485A-A439-CCD097E08FF6 Q34480894-AE7B518C-9BD0-496C-B1E3-A3A3E83F8B04 Q35119060-611B6BCC-95D2-4012-9E57-D74AF6B89A38 Q35373624-E257D17C-89B5-46BC-A9F8-A77ABEBDC4B1 Q36624751-EE9C668E-81A9-4304-A1F2-5200D023605D Q36952174-BAFF34C3-EB4B-4693-8706-131AD3085F83 Q37533694-27CEF725-B2C4-4392-9DF2-06D093DCCEA0 Q37995534-89294302-C285-4CEC-86EE-FE7A2F8D55BB Q50949041-6CA78C9E-C82D-48BA-955A-60A3E79689F6

P2860

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

http://www.wikidata.org/entity/Q33987096

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

@ast

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

@en

type

label

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

@ast

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

@en

prefLabel

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

@ast

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

@en

P1433

Q33987096-6F4F0BCA-E189-446C-B217-1D0C5312B31F

P1476

Q33987096-C6C233F0-C2B0-42A6-B669-82C09B5395F7

P2093

Q33987096-0862E939-A46B-4727-931A-E955BC3AC1F0

Q33987096-1F525C46-B5B6-4D1B-A23D-48D971412200

Q33987096-4611E0E2-1453-4EF0-8A43-9F9E4F8CCF1E

Q33987096-DA12C9ED-D116-4F35-A135-E8559F22E0F1

Q33987096-FF5EDBFA-BC5C-4427-A78D-D1C8A2EE5A5D

P2860

Q33987096-0CB3D5DD-ACBE-4856-9481-53FE972B6E30

Q33987096-12137598-FD54-4F50-9973-A6BADD47EA46

Q33987096-331D7808-0856-4DD8-882B-C512D949186F

Q33987096-335898CE-C1DA-4F12-8F9A-B25C35B52ACB

Q33987096-422003A9-952B-4172-962D-FE1AA540723F

Q33987096-6F8D3E0C-9BB5-4413-BA50-1AC6AA79D001

Q33987096-863FFCD8-B5F9-420B-81B9-F1DA7682DB55

Q33987096-8D99E911-479C-440D-B6B9-B6DE0790F8BF

Q33987096-939F185C-8A63-4751-9E0C-2874D07DB8A4

Q33987096-94BEBFBA-F8DB-43B9-B69C-A749FB809A2B

P304

Q33987096-B2570F8E-7962-44DF-A75C-94ADEA39AAC0

P31

Q33987096-8CCA233E-5C4E-41C6-B090-9758E0B917C1

P356

Q33987096-5F41A879-348C-4428-8664-9A3BCF0A251C

P433

Q33987096-644F24D7-C719-4D18-9706-78A35F17FBF6

P478

Q33987096-290FFE6B-0C55-4955-9EF1-4A00826F30A1

P577

Q33987096-B7BCA1CC-B303-42A9-8763-39DF7C62B599

P5875

Q33987096-9F97099C-4803-473C-BA36-B33B947269E9

P698

Q33987096-2AC95866-B45F-463E-9B10-326C24555A4D

P932

Q33987096-88BA0012-0F60-481E-846B-72B4D49B9CB3

P356

J.THROMRES.2010.04.003

P1433

Thrombosis Research

P1476

PGE2 decreases reactivity of human platelets by activating EP2 and EP4

@en

P2093

Elias V Haddad

http://www.w3.org/2001/XMLSchema#string

James P Smith

http://www.w3.org/2001/XMLSchema#string

Jason D Downey

http://www.w3.org/2001/XMLSchema#string

Olivier Boutaud

http://www.w3.org/2001/XMLSchema#string

Richard M Breyer

http://www.w3.org/2001/XMLSchema#string

P2860

A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling

Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation

Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors

Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels.

Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

Prostaglandin E receptors.

Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.

Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence.

P304

e23-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.THROMRES.2010.04.003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44582045

http://www.w3.org/2001/XMLSchema#string

P698

20451959

http://www.w3.org/2001/XMLSchema#string

P932

2902561

http://www.w3.org/2001/XMLSchema#string